ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.427,04
0,08%
S&P 500
5.652,53
0,38%
US Dollar vs BRL
5,4177
-0,56%
Bitcoin
64.001,98
-1,31%
Brent Oil
83,165
-1,39%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Champions Oncology Inc (CSBR)

  7. Champions Oncology Inc (CSBR) Notícias

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR
DataHoraFonteTítuloCódigoCompanhia
26/07/201817:02PR Newswire (US)Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018NASDAQ:CSBRChampions Oncology Inc
12/07/201809:30PR Newswire (US)Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018NASDAQ:CSBRChampions Oncology Inc
18/06/201809:30PR Newswire (US)Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PD...NASDAQ:CSBRChampions Oncology Inc
03/05/201809:30PR Newswire (US)Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9thNASDAQ:CSBRChampions Oncology Inc
01/05/201809:30PR Newswire (US)Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology ResearchNASDAQ:CSBRChampions Oncology Inc
04/04/201809:30PR Newswire (US)Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex HouseNASDAQ:CSBRChampions Oncology Inc
28/03/201818:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CSBRChampions Oncology Inc
19/03/201817:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CSBRChampions Oncology Inc
15/03/201817:01PR Newswire (US)Champions Oncology Reports Quarterly Revenue of $5.1 MillionNASDAQ:CSBRChampions Oncology Inc
15/03/201817:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CSBRChampions Oncology Inc
07/03/201810:30PR Newswire (US)Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018NASDAQ:CSBRChampions Oncology Inc
26/02/201810:30PR Newswire (US)Champions Oncology to Participate at the 30th Annual ROTH ConferenceNASDAQ:CSBRChampions Oncology Inc
21/02/201810:30PR Newswire (US)Motivated Patients with ROS1 Cancer Initiate Global Research StudyNASDAQ:CSBRChampions Oncology Inc
07/12/201719:15PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $5.2 MillionNASDAQ:CSBRChampions Oncology Inc
28/11/201711:05PR Newswire (US)Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017NASDAQ:CSBRChampions Oncology Inc
07/11/201711:00PR Newswire (US)Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor ConferenceNASDAQ:CSBRChampions Oncology Inc
26/09/201709:30PR Newswire (US)Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cance...NASDAQ:CSBRChampions Oncology Inc
18/09/201710:15PR Newswire (US)Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model resp...NASDAQ:CSBRChampions Oncology Inc
14/09/201717:30PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $5 MillionNASDAQ:CSBRChampions Oncology Inc
07/09/201718:00PR Newswire (US)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017NASDAQ:CSBRChampions Oncology Inc
31/08/201718:31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CSBRChampions Oncology Inc
28/08/201718:21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CSBRChampions Oncology Inc
21/08/201709:30PR Newswire (US)Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft ...NASDAQ:CSBRChampions Oncology Inc
18/08/201709:30PR Newswire (US)Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort o...NASDAQ:CSBRChampions Oncology Inc
15/08/201705:57PR Newswire (US)The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and La...NASDAQ:CSBRChampions Oncology Inc
08/08/201715:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CSBRChampions Oncology Inc
28/07/201717:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CSBRChampions Oncology Inc
27/07/201717:01PR Newswire (US)Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017NASDAQ:CSBRChampions Oncology Inc
17/07/201709:30PR Newswire (US)Champions Oncology Schedules Fourth Quarter and Fiscal Year 2017 Earnings CallNASDAQ:CSBRChampions Oncology Inc
16/03/201717:01PR Newswire (US)Champions Oncology Reports 40% Revenue GrowthNASDAQ:CSBRChampions Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR

Seu Histórico Recente

LSE
USPR
Ish Mscit Uspr
LSE
TELW
Lyxor Wld
LSE
EEJD
Is Jpn Ee Ud
NASDAQ
ZAIS
ZAIS Group Holdings, Inc.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados